Observational Study on the Combination of Selinexor With Bortezomib and Dexamethasone for the Treatment of MM Patients
NCT06933277
·
clinicaltrials.gov ↗
RECRUITING
Status
159
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto